ArticleCancer immunology, immunotherapy : CII2025

Nattokinase-driven remodeling of tumor microenvironment enhances the efficacy of MSLN-targeted CAR-T cell therapy in solid tumors.

Lianfeng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.